HIF1A and neoplasm: Whereas bevacizumab alone induced the expression of HIF-1-dependent genes, the addition of topotecan clearly abrogated HIF-1 transcriptional activity in the tumor microenvironment, and significantly inhibited proliferation and induced apoptosis of tumor cells [39].